Status:
COMPLETED
Phase 2 Study of KLS-0611 in Patients With Dry Eye Syndromes
Lead Sponsor:
Kissei Pharmaceutical Co., Ltd.
Conditions:
Dry Eye Syndromes
Eligibility:
All Genders
20+ years
Phase:
PHASE2
Brief Summary
To evaluate the efficacy and safety of KLS-0611 compared to placebo in patients with dry eye syndromes.
Eligibility Criteria
Inclusion
- Corneal and conjunctival damage
- Insufficiency of lacrimal secretion
- Ocular symptom
Exclusion
- Severe ophthalmic disorder
- Punctual plugs or surgery for occlusion of the lacrimal puncta
Key Trial Info
Start Date :
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT00721656
Last Update
March 18 2009
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
Japan
Hokkaido Region, Japan
2
Japan
Kansai Region, Japan
3
Japan
Kanto Region, Japan
4
Japan
Kyushu Region, Japan